Furthermore, p53AIP1 and survivin expressions in non-small cell lung cancer cells before chemotherapy may contribute as independent predictors of the effect of chemotherapy, such as DNA-damaging agents. The gene discussed is BIRC5; the disease is non-small cell lung carcinoma.